Webinars Resources

Evaluating the Quality of Real-World Evidence

The Role of Real-World Evidence in Regulatory Decision-Making

Optimizing Digital Health Trials by Engaging Patients and Sites

Register now for this webinar on Jan. 12 at 2 p.m. Speakers include, Virginia Nido, Global Head, Product Development Industry Collaborations, Genentech; and Cindy Geoghegan, Patient Advocate.

Current Landscape of Patient-Generated Data and Data Privacy

Multi-Criteria Decision Analysis: Can It Help Make Value Assessment More Patient-Centered?

Join us on Nov. 19 from 11:00 a.m. – 12:00 p.m. ET for a webinar, held in tandem with release of a white paper summarizing findings from a Roundtable on Patient-Centered Multi-Criteria Decision Analysis (MCDA), co-hosted by the NHC and National Pharmaceutical Council earlier this year. Speakers will introduce MCDA and describe comments, suggestions, and takeaways that emerged during the discussion.

Sources of RWD: An Introduction to Patient Registries

Sources of RWD: An Introduction to “Big Data”

This webinar will introduce big data, an umbrella term used to describe some types of real-world data. Big data can come from health care visits, including information from electronic health records and insurance claims, and it also can come from “non-traditional” sources such as social media and wearable devices.

Real-World Data and Real-World Evidence 101

This webinar will introduce essential terminology related to real-world data (RWD) and real-world evidence (RWE). We will discuss how RWE complements evidence from traditional randomized clinical trials and highlight case examples.

Health Literacy Throughout Drug Development: Why it Matters to Pharma and to Patients